Chengyin Min

Title: Chengyin Min: Innovator in Pharmaceutical Combinations

Introduction

Chengyin Min is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of combinations that target cancer treatment. With a total of 3 patents, his work has the potential to impact the lives of many patients.

Latest Patents

Chengyin Min's latest patents include innovative pharmaceutical combinations. One of his notable patents is for a combination comprising a histone deacetylase inhibitor and a BCL-2 inhibitor. This patent outlines methods for using this combination in the treatment or prevention of cancer. Another significant patent involves pharmaceutical combinations of histone deacetylase inhibitors and CD20 inhibitory antibodies, aimed at treating B-cell disorders, including cancer.

Career Highlights

Throughout his career, Chengyin Min has worked with various companies, including Acetylon Pharmaceuticals, Inc. His experience in the pharmaceutical industry has allowed him to develop groundbreaking treatments that address critical health issues.

Collaborations

Chengyin Min has collaborated with professionals such as Simon Steward Jones and Steven N Quayle. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Chengyin Min is a distinguished inventor whose work in pharmaceutical combinations is paving the way for innovative cancer treatments. His contributions to the field are invaluable and continue to inspire future research and development.